Page last updated: 2024-10-24

candesartan cilexetil and Cerebrovascular Disorders

candesartan cilexetil has been researched along with Cerebrovascular Disorders in 3 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, S1
Ohta, K1
Hamaguchi, A1
Omura, T1
Yukimura, T1
Miura, K1
Inada, Y2
Wada, T2
Ishimura, Y2
Chatani, F1
Ojima, M1
Sanada, T1
Shibouta, Y1
Kanagawa, R1
Fujisawa, Y1
Nishikawa, K2

Reviews

1 review available for candesartan cilexetil and Cerebrovascular Disorders

ArticleYear
Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Journal of human hypertension, 1998, Volume: 12, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun

1998

Other Studies

2 other studies available for candesartan cilexetil and Cerebrovascular Disorders

ArticleYear
Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
    Blood pressure. Supplement, 1994, Volume: 5

    Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Ben

1994
Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1997, Volume: 19, Issue:7

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiote

1997